Price
$22.58-29.24%1Y
1M+9.75%1Y-29.24%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Lagging2/10
Value54
Quality39
Momentum22
Growth30
P/E (TTM)-
Market Cap$10.27B
1Y Return-29.24%
5Y Return-71.53%
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $1.38B (-6.30%)
●Advanced Surgery grew +13.79% YoY●Infusion Therapies And Technologies -9.93% YoY
SegmentLatestQoQYoY
- Infusion Therapies And Technologies$526.0M-5.23%-9.93%
- Care And Connectivity Solutions$315.0M-9.48%-0.32%
- Front Line Care$198.0M-13.54%-1.98%
- Injectables And Anesthesia$180.0M+1.69%-7.69%
- Advanced Surgery$165.0M-1.79%+13.79%
- Acute Therapies---
- BPS---
- Bio Pharma Solutions---
- Chronic Renal---
- Clinical Nutrition---
- Medication Delivery---
- Other---
- Other Product Or Services---
- Patient Support Systems---
- Pharmaceutical Compounding$0.00--
- Pharmaceuticals---
- Renal---
- Surgical Solutions---